Journey Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Journey Medical Corp
DERM Stock  USD 7.73  0.02  0.26%   
Journey Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Journey Medical's valuation are provided below:
Gross Profit
39.2 M
Profit Margin
(0.15)
Market Capitalization
256.4 M
Enterprise Value Revenue
4.3115
Revenue
59.4 M
There are over one hundred nineteen available fundamental trends for Journey Medical Corp, which can be analyzed over time and compared to other ratios. Self-guided Investors are advised to confirm Journey Medical's regular fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 14th of February 2026, Market Cap is likely to drop to about 120.6 M. In addition to that, Enterprise Value is likely to drop to about 106.4 M

Journey Medical Total Revenue

43.56 Million

Check Journey Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Journey Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.2 M, Interest Expense of 4 M or Selling General Administrative of 52.9 M, as well as many indicators such as Price To Sales Ratio of 1.55, Dividend Yield of 0.0 or PTB Ratio of 3.81. Journey financial statements analysis is a perfect complement when working with Journey Medical Valuation or Volatility modules.
  
Build AI portfolio with Journey Stock
Check out the analysis of Journey Medical Correlation against competitors.

Journey Medical Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets68.6 M72.2 M171.6 M
Slightly volatile
Short and Long Term Debt Total22 M23.1 M75.8 M
Pretty Stable
Total Current Liabilities46.1 M40.5 M35 M
Slightly volatile
Property Plant And Equipment Net170.1 K179.1 K369.2 K
Pretty Stable
Accounts Payable15.5 M18.5 M12.4 M
Slightly volatile
Cash17.4 M18.3 M59.1 M
Slightly volatile
Non Current Assets Total17.2 M28.9 M33.8 M
Slightly volatile
Non Currrent Assets Other5.1 K5.4 K641.6 K
Slightly volatile
Cash And Short Term Investments17.4 M18.3 M117.3 M
Slightly volatile
Net Receivables17 M11.8 M13.7 M
Slightly volatile
Good Will616.8 K693.9 K757.4 K
Slightly volatile
Common Stock Shares Outstanding19.9 M18.4 M24.2 M
Slightly volatile
Short Term Investments181 M239.3 M156.4 M
Slightly volatile
Liabilities And Stockholders Equity68.6 M72.2 M171.6 M
Slightly volatile
Non Current Liabilities Total21.4 M22.5 M50.4 M
Very volatile
Other Current Assets3.1 M2.9 M3.1 M
Pretty Stable
Other Stockholder Equity91.6 M96.4 M184.5 M
Very volatile
Total Liabilities89 M54.2 M86.2 M
Pretty Stable
Total Current Assets41.2 M43.4 M137.2 M
Slightly volatile
Short Term Debt773.5 K814.2 K1.5 M
Pretty Stable
Intangible Assets38.5 M36.6 M12.4 M
Slightly volatile
Common Stock1.7 K1.8 K17 K
Slightly volatile
Inventory9.3 M16.6 M9 M
Slightly volatile
Other Assets81.2 K85.5 K783 K
Slightly volatile
Long Term Debt15.3 M28.6 M10.6 M
Slightly volatile
Capital Lease Obligations158.2 K231.2 K117.6 K
Slightly volatile
Net Invested Capital34.1 M51.7 M20.2 M
Slightly volatile
Property Plant And Equipment Gross157.5 K228.8 K123.5 K
Slightly volatile
Capital Stock1.8 K2.3 K1.4 K
Slightly volatile
Non Current Liabilities Other1.2 M1.3 M4 M
Slightly volatile
Net Working Capital15.2 M15 M9 M
Slightly volatile
Property Plant Equipment149.1 K217.3 K122.8 K
Slightly volatile
Other Liabilities6.8 K7.2 K66.8 K
Slightly volatile
Short and Long Term Debt2.1 M3.4 M1.4 M
Slightly volatile

Journey Medical Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization4.2 M4 M1.6 M
Slightly volatile
Interest Expense4 M3.1 M2.8 M
Slightly volatile
Selling General Administrative52.9 M46.2 M38.9 M
Slightly volatile
Total Revenue43.6 M64.6 M33.7 M
Slightly volatile
Gross Profit29.9 M40.5 M23.4 M
Slightly volatile
Other Operating Expenses88.5 M62.8 M89.7 M
Pretty Stable
Total Operating Expenses78.6 M44 M79.9 M
Very volatile
Cost Of Revenue21.5 M24 M11.3 M
Slightly volatile
Tax Provision52.2 K54.9 K1 M
Slightly volatile
Reconciled Depreciation2.7 M4 M1.3 M
Slightly volatile

Journey Medical Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation6.1 M5.5 M6 M
Very volatile
Begin Period Cash Flow47 M24.7 M47.4 M
Very volatile
Depreciation4.1 M3.9 M1.6 M
Slightly volatile
Capital Expenditures18.1 M17.2 M5.4 M
Slightly volatile
End Period Cash Flow17.4 M18.3 M52.6 M
Pretty Stable
Change To Operating Activities664.3 K699.3 K7.4 M
Slightly volatile
Change To Netincome26.5 M25.3 M8.6 M
Slightly volatile
Dividends Paid317.2 K333.9 K1.2 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.551.6431.0421
Slightly volatile
Days Sales Outstanding14776.5206
Slightly volatile
Stock Based Compensation To Revenue0.120.10860.7143
Pretty Stable
Capex To Depreciation2.263.942.9711
Very volatile
EV To Sales1.661.7527.955
Slightly volatile
Inventory Turnover1.581.662.1573
Slightly volatile
Days Of Inventory On Hand5242901.5 K
Slightly volatile
Payables Turnover2.781.51.3293
Slightly volatile
Sales General And Administrative To Revenue3.973.673.6142
Slightly volatile
Research And Ddevelopement To Revenue0.190.23.5507
Slightly volatile
Capex To Revenue0.250.240.0935
Slightly volatile
Cash Per Share1.091.142.9401
Pretty Stable
Days Payables Outstanding3073232.7 K
Slightly volatile
Intangibles To Total Assets0.380.360.1435
Slightly volatile
Current Ratio1.51.585.0529
Slightly volatile
Receivables Turnover5.996.317.891
Very volatile
Capex Per Share0.690.660.2558
Slightly volatile
Revenue Per Share1.572.471.5398
Slightly volatile
Interest Debt Per Share2.041.61.4189
Pretty Stable
Debt To Assets0.310.370.251
Slightly volatile
Graham Number1.21.891.3283
Slightly volatile
Operating Cycle555367443
Very volatile
Days Of Payables Outstanding3073232.7 K
Slightly volatile
Ebt Per Ebit0.870.961.0497
Pretty Stable
Long Term Debt To Capitalization0.420.50.4121
Slightly volatile
Total Debt To Capitalization0.40.510.3958
Slightly volatile
Quick Ratio1.051.14.9179
Slightly volatile
Net Income Per E B T0.760.90.9543
Slightly volatile
Cash Ratio0.630.662.2719
Slightly volatile
Days Of Inventory Outstanding5242901.5 K
Slightly volatile
Days Of Sales Outstanding14776.5206
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.03920.04121.1047
Very volatile
Fixed Asset Turnover213254209
Slightly volatile
Debt Ratio0.310.370.251
Slightly volatile
Price Sales Ratio1.551.6431.0421
Slightly volatile
Asset Turnover0.380.630.3776
Slightly volatile
Gross Profit Margin0.740.720.8204
Slightly volatile

Journey Medical Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap120.6 M120.8 M136.4 M
Slightly volatile
Enterprise Value106.4 M109.6 M130.8 M
Slightly volatile

Journey Fundamental Market Drivers

Forward Price Earnings32.0513
Cash And Short Term Investments20.3 M

Journey Upcoming Events

3rd of April 2024
Upcoming Quarterly Report
View
27th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
3rd of April 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Journey Medical Financial Statements

Journey Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Journey Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue-529.2 K-502.7 K
Total Revenue64.6 M43.6 M
Cost Of Revenue24 M21.5 M
Stock Based Compensation To Revenue 0.11  0.12 
Sales General And Administrative To Revenue 3.67  3.97 
Research And Ddevelopement To Revenue 0.20  0.19 
Capex To Revenue 0.24  0.25 
Revenue Per Share 2.47  1.57 
Ebit Per Revenue(0.22)(0.23)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:
How To Invest In Journey
Details
Is Journey Stock a good investment?
Details
What is Journey Medical's Net Worth?
Details
Largest Biotechnology Companies
View
Largest Pharmaceuticals, Biotechnology & Life Sciences Companies
View
Check out the analysis of Journey Medical Correlation against competitors.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Biotechnology sector continue expanding? Could Journey diversify its offerings? Factors like these will boost the valuation of Journey Medical. Projected growth potential of Journey fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Journey Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.35)
Revenue Per Share
2.577
Quarterly Revenue Growth
0.205
Return On Assets
(0.05)
Return On Equity
(0.47)
Understanding Journey Medical Corp requires distinguishing between market price and book value, where the latter reflects Journey's accounting equity. The concept of intrinsic value - what Journey Medical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Journey Medical's price substantially above or below its fundamental value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Earnings
Projections
Details
It's important to distinguish between Journey Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Journey Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Journey Medical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY